Dr. Elias is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
41 Alvarado Rd.
Berkeley, CA 94705Phone+1 510-299-2133- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1976 - 1977
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1974 - 1976
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1973 - 1974
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1972 - 1973
- Stanford University School of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1973 - 2014
Clinical Trials
- Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer Start of enrollment: 1998 Jul 01
- Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer Start of enrollment: 1996 Aug 01
- Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer Start of enrollment: 2000 Nov 01
Publications & Presentations
PubMed
- 30 citationsIbrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.Paul G. Richardson, William I. Bensinger, Carol Ann Huff, Caitlin Costello, Nikoletta Lendvai, Jesus G. Berdeja, Larry D. Anderson, David S. Siegel, Daniel Lebovic, Su...> ;British Journal of Haematology. 2018 Mar 1
- 62 citationsImmune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemiaHanna Jean Khoury, Robert H. Collins, William Blum, Patrick S. Stiff, Laurence Elias, Jane S. Lebkowski, Anita Reddy, Kevin Nishimoto, Debasish Sen, Edward D. Wirth, C...> ;Cancer. 2017 Aug 15
- 52 citationsIbrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth.Jun Chen, Taisei Kinoshita, Juthamas Sukbuntherng, Betty Chang, Laurence Elias> ;Molecular Cancer Therapeutics. 2016 Dec 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: